Deals & Cases |
Deals & Cases | 13 April 2017
BioVersys CHF 5.5 Mio. Series A Round
Walder Wyss advises BioVersys AG, Basel, on its Extended Series A financing Round. The financing round amounts to CHF 5.5 mio. was subscribed by existing shareholders.
The Walder Wyss teams consisted of Alexander Gutmans (Partner, Corporate Venture Capital, Life Sciences), Reto Vonzun (Partner, Corporate) and Ayesha Curmally (Partner, notarial services).
More News
-
Deals & Cases | -
Deals & Cases |CeQur SA raises USD 100 Million Series E Financing Round
-
Deals & Cases |Cosaic closes USD 6 million Late Seed Financing Round
-
Deals & Cases |Planetary announces USD 28 million Series A Financing Round
-
Deals & Cases |Oversubscribed Series A Financing Round of Xsensio SA
-
Deals & Cases |Walder Wyss advises UVC Partners as lead investor in USD 24 million financing round of Metafuels AG
-
Corporate News |Swiss Venture Capital Report 2026
-
Deals & Cases |Walder Wyss advises investor on financing round of Flexion
-
Deals & Cases |Swiss MedTech company Distalmotion SA closes USD 150m Series G Financing Round
-
Deals & Cases |Walder Wyss advised Flexstone Partners in Ecorobotix’s Series D